Tag: Annex 1

Temporary Facilities and Pilot Plants: Contamination Control Expectations Comprehensive Guide to Contamination Control in Temporary Facilities and Pilot Plants for Aseptic Manufacturing The pharmaceutical industry’s increasing reliance on temporary facilities and pilot plants for aseptic manufacturing places heightened focus on contamination control measures. Ensuring compliance with regulatory expectations as outlined in Annex 1 to the…

Read More “Temporary Facilities and Pilot Plants: Contamination Control Expectations” »

CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics Comprehensive CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics The manufacture of non-classical pharmaceutical modalities such as viral vectors, vaccines, and biologics presents unique contamination control and sterility assurance challenges. Applicable regulations and guidances—including ICH Q9 on Quality Risk Management, FDA 21 CFR Part 211,…

Read More “CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics” »

Contamination Control at Interfaces Between Classified and Non-Classified Areas Effective Contamination Control at Interfaces Between Classified and Non-Classified Areas in Aseptic Manufacturing Maintaining contamination control within pharmaceutical aseptic manufacturing environments is essential to ensuring patient safety, product sterility, and regulatory compliance. A critical aspect of contamination control is the management of interfaces between classified cleanrooms…

Read More “Contamination Control at Interfaces Between Classified and Non-Classified Areas” »

Handling Deviations From Standard Gowning or Entry Procedures Step-by-Step Guide: Handling Deviations from Standard Gowning or Entry Procedures in Aseptic Manufacturing In pharmaceutical aseptic manufacturing, proper gowning and entry procedures are fundamental to maintaining critical contamination control and safeguarding product sterility assurance. Deviations from these established procedures pose risks to cleanroom integrity and may lead…

Read More “Handling Deviations From Standard Gowning or Entry Procedures” »

Impact of Human Resource Constraints on Contamination Control and Annex 1 Risk How Human Resource Constraints Affect Contamination Control and Annex 1 Compliance in Aseptic Manufacturing Ensuring effective contamination control in aseptic manufacturing remains a core objective amid the evolving challenges encountered within pharmaceutical production environments. Human resources (HR) play a critical role in maintaining…

Read More “Impact of Human Resource Constraints on Contamination Control and Annex 1 Risk” »

Aligning CCS With Site Master File, VMP and PQS Documentation Step-by-Step Guide to Aligning Contamination Control Strategy With Site Master File, VMP and PQS Documentation Effective contamination control is the cornerstone of aseptic manufacturing and sterility assurance in pharmaceutical production. Harmonizing your contamination control strategy (CCS) with the Site Master File (SMF), Validation Master Plan…

Read More “Aligning CCS With Site Master File, VMP and PQS Documentation” »

Defining KPIs and KRIs for Contamination Control Performance Effective Definition of KPIs and KRIs for Contamination Control in Aseptic Manufacturing Contamination control remains one of the most critical aspects of pharmaceutical manufacturing, especially in aseptic processing environments. Regulatory bodies such as the FDA, EMA, MHRA, and PIC/S emphasize the importance of maintaining stringent contamination control…

Read More “Defining KPIs and KRIs for Contamination Control Performance” »

Using Data Analytics on EM and Utility Data to Spot Emerging Contamination Risks Applying Data Analytics to Environmental and Utility Data for Enhanced Contamination Control in Aseptic Manufacturing Pharmaceutical aseptic manufacturing demands rigorous control strategies to ensure product sterility and patient safety. With the revisions of Annex 1 and heightened regulatory expectations across the EU…

Read More “Using Data Analytics on EM and Utility Data to Spot Emerging Contamination Risks” »

Risk-Based Reduction of EM Points: When Is It Justified and How to Defend It? Risk-Based Reduction of Environmental Monitoring Points: A Step-by-Step GMP Guide Aligned with Annex 1 Environmental monitoring (EM) is critical for maintaining contamination control within aseptic manufacturing environments. Regulatory bodies such as the FDA, EMA, MHRA, and PIC/S mandate strict environmental monitoring…

Read More “Risk-Based Reduction of EM Points: When Is It Justified and How to Defend It?” »

Setting Up EM and CCS for New Facilities Before First GMP Production Step-by-Step Guide to Setting Up Environmental Monitoring and Contamination Control Strategy in New GMP Facilities Establishing an effective environmental monitoring (EM) and contamination control strategy (CCS) is a cornerstone of compliance and sterility assurance in aseptic manufacturing. Prior to initiating first Good Manufacturing…

Read More “Setting Up EM and CCS for New Facilities Before First GMP Production” »